MedTech Europe has reiterated the importance of tariff-free trade for medical technologies following the US decision to impose reciprocal tariffs of 15% on most goods from Europe.

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA).

The FDA has granted a second 510(k) clearance to expand the use of Respiree’s RS001 cardio-respiratory wearable to home use.

Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Becton, Dickinson and Company (BD) has announced its submission of an application to the FDA for an at-home human papillomavirus (HPV) test.

Trividia Health UK has launched the TRUEplus 5-Bevel Pen Needles in the country, marking the product's first entry outside the US.

Founder Juan José Chacón-Quiros discusses how Establishment Labs is transforming breast reconstruction and aesthetics with innovative, patient-focused solutions.

Regulatory and supply chain pressures place scaling medical device companies under strain. Expert partners can help ease these pain points.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.